Occudo Quantitative Strategies LP Next Cure, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.7 - $9.1 $70,206 - $112,084	-12,317 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.74 - $8.02 $11,356 - $13,513	-1,685 Reduced 12.03%	12,317 $83,000
Q2 2021 Aug 16, 2021	SELL	$7.6 - $10.28 $49,308 - $66,696	-6,488 Reduced 31.66%	14,002 $112,000
Q1 2021 May 14, 2021	SELL	$9.81 - $13.88 $106,605 - $150,833	-10,867 Reduced 34.66%	20,490 $205,000
Q4 2020 Feb 16, 2021	BUY	$9.47 - $12.43 $296,950 - $389,767	31,357 New	31,357 $342,000

17.4M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $19.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.